Distinction Between Papillary Thyroid Hyperplasia and Papillary Thyroid Carcinoma by Immunohistochemical Staining for Cytokeratin 19, Galectin-3, and HBME-1
- 1 January 2003
- journal article
- research article
- Published by Springer Nature in Endocrine Pathology
- Vol. 14 (1) , 55-60
- https://doi.org/10.1385/ep:14:1:55
Abstract
The histopathology of papillary thyroid hyperplasia and papillary thyroid carcinoma is similar enough to cause a diagnostic dilemma in a few cases. Both lesions may have papillary fronds with...Keywords
This publication has 14 references indexed in Scilit:
- Cytokeratin 19 Immunoreactivity in the Diagnosis of Papillary Thyroid CarcinomaAmerican Journal of Clinical Pathology, 2001
- Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesionsThe Lancet, 2001
- Immunohistochemical Diagnosis of Papillary Thyroid CarcinomaLaboratory Investigation, 2001
- p27kip1 Expression Distinguishes Papillary Hyperplasia in Graves' Disease from Papillary Thyroid CarcinomaLaboratory Investigation, 2000
- Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formationHuman Pathology, 2000
- HBME-1 immunostaining in thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma.1997
- GALECTIN-3 AND LAMININ EXPRESSION IN NEOPLASTIC AND NON-NEOPLASTIC THYROID TISSUEThe Journal of Pathology, 1997
- Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications.1995
- High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors.1994
- Expression of Keratin 19 Distinguishes Papillary Thyroid Carcinoma from Follicular Carcinoma and Follicular Thyroid AdenomaAmerican Journal of Clinical Pathology, 1989